Schrodinger SDGR Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Gross Profit by Business | |||||
| Software | $148.5M+3.5% | $143.47M+10.7% | $129.61M+22.3% | $106M+22.2% | |
| Total revenues by Product | |||||
| Hosted software | $45.12M+28.0% | $35.25M+73.0% | $20.38M+36.9% | $14.89M+34.4% | |
| On-premise software | $101.45M-2.5% | $104.02M-0.5% | $104.51M+23.7% | $84.49M+13.3% | |
| Professional services | $9.65M-1.5% | $9.8M+4.6% | $9.37M-38.4% | $15.21M+64.1% | |
| Software maintenance | $27.29M+17.2% | $23.28M+0.9% | $23.07M+15.4% | $20M+15.6% | |
| Software products and services | $195.66M+8.5% | $180.37M+13.3% | $159.12M+17.4% | $135.58M+19.7% | |
| Drug discovery services revenue from contracts with customers by Product | |||||
| Drug Discovery Services | $50.22M+99.8% | $25.14M-54.1% | $54.72M+26.0% | $43.43M— | |
| Revenue from contracts with customers | $183.51M+6.5% | $172.35M+9.6% | $157.32M+16.9% | $134.58M+19.9% | |
| Receivable, after allowance for credit loss, current by Product | |||||
| Oncology, Neurology, and Immunology Product | $0— | —— | —— | —— | |
| Software contribution | $0— | —— | —— | —— | |
| Restricted cash (includes related party amounts of $0 and $72, respectively) by Product | |||||
| Software contribution | $12.89M— | —— | —— | —— | |
| Total revenues by Geography | |||||
| APAC | $75.16M+12.9% | $66.55M+128% | $29.14M-15.4% | $34.45M+19.3% | |
| EMEA | $26.18M+5.2% | $24.9M+1.3% | $24.57M+13.3% | $21.68M+21.9% | |
| Rest of World | $1.56M+28.2% | $1.22M+21.7% | $1M-87.3% | $7.87M— | |
| United States | $152.96M+33.2% | $114.87M-29.1% | $161.96M+31.1% | $123.56M+36.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Schrodinger break its business down?
- Schrodinger (SDGR) reports gross profit by business across 2 parts — Drug Discovery and Software. Each is extracted from the segment footnotes and tracked over time.
- Where does Schrodinger's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Schrodinger's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
